Areteia Therapeutics introduces dexpramipexole, a novel oral drug in Phase 3 trials for asthma and COPD, aiming for approval ...

What makes the guidelines issued by NYU Langone and NYC Health + Hospitals especially foreboding is that both memos directly ...

ADMA Biologics' growth potential with Asceniv makes it a compelling Buy. Click here to find out why ADMA stock is a Strong ...

The Times also says the Bank's alert is a setback for Reeves as it says there was a warning of a new squeeze on living standards. The Bank cut interest rates to 4.5% as it attempts to stimulate the ...

Presentation Unidentified Speaker Thank you. Thank you, Julianne. Good afternoon, everyone, and welcome to our 4th-quarter ...

Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Good evening. My name is Rob, and I will be your conference ...

Amgen's Q4 2024 earnings show a 19% revenue increase year-on-year, with non-GAAP EPS up 13% in Q4 and 6% for the full year.

According to a recent report by Future Market Insights (FMI), the global bronchoscopes market is poised for significant growth, with an estimated sales value of USD 501.0 Million by the end of 2022.